Precocious puberty generally refers to the premature development of secondary sexual characteristics, which is recognized when secondary sexual characteristics appear before two standard deviations from the age of normal sexual development (mean). In males, secondary sexual characteristics are characterized by significant growth of pubic hair, armpit hair, and beard, development of muscles and bones, protrusion of the larynx, and a lowered voice. In females, it is characterized by breast augmentation, growth of pubic and axillary hair, increase in the width of the pelvis, and the appearance of rich fat under the skin. The aim of the treatment of precocious puberty is to eliminate the cause of the disease, inhibit sexual development, and promote the attainment of final height. Drugs used to inhibit sexual development include megestrol acetate, cyproterone acetate, chlordiazepoxide and danazol. Patients with precocious puberty should consult a medical professional for treatment.